By applying the technology created by Baker's team, Cyrus scientists are solving some of the biggest challenges of protein drugs, while also developing our own algorithms and new datasets in-house and with the Openfold AI consortium that Cyrus... businesswire.com/news/home/2…
Rosetta, and Steven Lewis's work on computational design of bispecific antibodies is being discussed at the keynote speech #PEG2016
1